APOL5
gene geneOn this page
Also known as APOLV
Summary
APOL5 (apolipoprotein L5, HGNC:14869) is a protein-coding gene on chromosome 22q12.3, encoding Apolipoprotein L5 (Q9BWW9). May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.
This gene is a member of the apolipoprotein L gene family. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles.
Source: NCBI Gene 80831 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_030642
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14869 |
| Approved symbol | APOL5 |
| Name | apolipoprotein L5 |
| Location | 22q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | APOLV |
| Ensembl gene | ENSG00000128313 |
| Ensembl biotype | protein_coding |
| OMIM | 607255 |
| Entrez | 80831 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000249044
RefSeq mRNA: 1 — MANE Select: NM_030642
NM_030642
CCDS: CCDS13920
Canonical transcript exons
ENST00000249044 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000880021 | 35726211 | 35727194 |
| ENSE00000880022 | 35728723 | 35728904 |
| ENSE00000911244 | 35717872 | 35717926 |
| ENSE00000936034 | 35729354 | 35729483 |
| ENSE00001275737 | 35720568 | 35720654 |
Expression profiles
Bgee: expression breadth broad, 36 present calls, max score 84.33.
Top tissues by expression
99 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.33 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.37 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 59.00 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 57.41 | gold quality |
| muscle of leg | UBERON:0001383 | 53.23 | gold quality |
| gastrocnemius | UBERON:0001388 | 50.61 | gold quality |
| muscle tissue | UBERON:0002385 | 50.05 | gold quality |
| right lobe of liver | UBERON:0001114 | 47.75 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 46.69 | silver quality |
| liver | UBERON:0002107 | 46.66 | gold quality |
| gall bladder | UBERON:0002110 | 44.48 | gold quality |
| apex of heart | UBERON:0002098 | 42.11 | silver quality |
| prefrontal cortex | UBERON:0000451 | 40.60 | gold quality |
| heart left ventricle | UBERON:0002084 | 39.53 | gold quality |
| left testis | UBERON:0004533 | 39.30 | gold quality |
| testis | UBERON:0000473 | 38.78 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 38.61 | silver quality |
| primary visual cortex | UBERON:0002436 | 38.45 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 37.98 | silver quality |
| thoracic mammary gland | UBERON:0005200 | 37.75 | gold quality |
| frontal cortex | UBERON:0001870 | 37.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.36 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| right testis | UBERON:0004534 | 37.14 | gold quality |
| heart | UBERON:0000948 | 37.01 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 36.24 | silver quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.03 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting APOL5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-4317 | 98.49 | 67.09 | 987 |
| HSA-MIR-1912-5P | 97.94 | 67.98 | 832 |
| HSA-MIR-3152-5P | 96.98 | 66.88 | 819 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
Literature-anchored findings (GeneRIF, showing 1)
- APOL5 has been found only in humans (PMID:11374903)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | apol | ENSDARG00000073718 |
| caenorhabditis_elegans | WBGENE00017219 | |
| caenorhabditis_elegans | WBGENE00017220 |
Paralogs (6): APOL4 (ENSG00000100336), APOL1 (ENSG00000100342), APOL3 (ENSG00000128284), APOL2 (ENSG00000128335), APOLD1 (ENSG00000178878), APOL6 (ENSG00000221963)
Protein
Protein identifiers
Apolipoprotein L5 — Q9BWW9 (reviewed: Q9BWW9)
Alternative names: Apolipoprotein L-V
All UniProt accessions (1): Q9BWW9
UniProt curated annotations — full annotation on UniProt →
Function. May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles.
Subcellular location. Cytoplasm.
Tissue specificity. Low level of expression; detected in uterus, testis, skeletal muscle and stomach.
Similarity. Belongs to the apolipoprotein L family.
RefSeq proteins (1): NP_085145* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008405 | ApoL | Family |
Pfam: PF05461
UniProt features (8 total): sequence variant 4, compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BWW9-F1 | 41.66 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
GOBP_LIPOPROTEIN_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_LOCALIZATION, GOMF_PROTEIN_LIPID_COMPLEX_BINDING, GOMF_LIPID_BINDING, GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING, GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING, ZNF22_TARGET_GENES, MIR4317, chr22q12, DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS, DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS, NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP, GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN
GO Biological Process (3): lipid metabolic process (GO:0006629), lipid transport (GO:0006869), lipoprotein metabolic process (GO:0042157)
GO Molecular Function (2): high-density lipoprotein particle binding (GO:0008035), lipid binding (GO:0008289)
GO Cellular Component (2): extracellular region (GO:0005576), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| primary metabolic process | 1 |
| transport | 1 |
| lipid localization | 1 |
| protein metabolic process | 1 |
| lipoprotein particle binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
304 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| APOL5 | COMT | P21964 | 649 |
| APOL5 | HPR | P00739 | 478 |
| APOL5 | CIMIP2C | A6NJV1 | 447 |
| APOL5 | APOC4 | P55056 | 419 |
| APOL5 | PI4KB | P78405 | 415 |
| APOL5 | APOO | Q9BUR5 | 399 |
| APOL5 | NT5DC4 | Q86YG4 | 393 |
| APOL5 | APOF | Q13790 | 377 |
| APOL5 | NAPRT | Q6XQN6 | 372 |
| APOL5 | ZNF441 | Q8N8Z8 | 371 |
| APOL5 | APOL1 | O14791 | 363 |
| APOL5 | YKT6 | O15498 | 362 |
| APOL5 | APOL4 | Q9BPW4 | 352 |
| APOL5 | APOLD1 | Q96LR9 | 351 |
| APOL5 | APOM | O95445 | 336 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ABL1 | APOL5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| APOL5 | CRK | psi-mi:“MI:0915”(physical association) | 0.400 |
| SRC | APOL5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FYN | APOL5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GRB2 | APOL5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| APOL5 | NCK1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| APOL5 | PIK3R1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| APOL5 | CLTCL1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): CLTCL1 (Affinity Capture-MS), APOL5 (Affinity Capture-MS)
ESM2 similar proteins: A0A140LIF8, A0JN92, A7UHZ5, O08602, O08603, O08604, O14791, O15482, O77812, O95236, P01574, P01575, P01576, P01577, P01578, P05012, P59045, P70499, Q2KHK6, Q3B7D9, Q3TR54, Q3UQS2, Q56XQ0, Q5NCI0, Q5PPP4, Q5RFJ8, Q60766, Q6AYC2, Q6XZW6, Q6ZSC3, Q7TPX8, Q80ZF2, Q810Y8, Q86WN2, Q8BVM9, Q8CB12, Q8CCN1, Q8TCY9, Q99388, Q99J64
Diamond homologs: O14791, O95236, Q9BPW4, Q9BQE5, Q9BWW8, Q9BWW9, Q96LR9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 69 |
| Likely benign | 6 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
685 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:35720460:A:AG | acceptor_gain | 0.9900 |
| 22:35717924:CTGG:C | donor_loss | 0.9800 |
| 22:35717927:G:GG | donor_gain | 0.9800 |
| 22:35726270:A:AG | acceptor_gain | 0.9800 |
| 22:35726271:G:GG | acceptor_gain | 0.9800 |
| 22:35720461:A:G | acceptor_gain | 0.9700 |
| 22:35726271:GTGAT:G | acceptor_gain | 0.9700 |
| 22:35717923:CCTG:C | donor_gain | 0.9500 |
| 22:35717925:TG:T | donor_gain | 0.9500 |
| 22:35717926:GG:G | donor_gain | 0.9500 |
| 22:35720581:TTGTA:T | donor_gain | 0.9500 |
| 22:35726397:A:G | acceptor_gain | 0.9500 |
| 22:35728753:T:TA | acceptor_gain | 0.9500 |
| 22:35717924:CTG:C | donor_gain | 0.9400 |
| 22:35726394:A:AG | acceptor_gain | 0.9400 |
| 22:35720468:A:AG | acceptor_gain | 0.9300 |
| 22:35726271:GT:G | acceptor_gain | 0.9300 |
| 22:35729352:A:AG | acceptor_gain | 0.9300 |
| 22:35729353:G:GG | acceptor_gain | 0.9300 |
| 22:35726395:C:G | acceptor_gain | 0.9100 |
| 22:35729352:AGTT:A | acceptor_gain | 0.9100 |
| 22:35729353:GTTG:G | acceptor_gain | 0.9100 |
| 22:35726393:CACA:C | acceptor_gain | 0.8800 |
| 22:35726394:ACAA:A | acceptor_gain | 0.8800 |
| 22:35726270:AGT:A | acceptor_gain | 0.8700 |
| 22:35726271:GTG:G | acceptor_gain | 0.8700 |
| 22:35726307:A:C | acceptor_gain | 0.8700 |
| 22:35727191:GAAG:G | donor_gain | 0.8500 |
| 22:35720582:T:TA | donor_gain | 0.8200 |
| 22:35728721:AG:A | acceptor_gain | 0.8200 |
AlphaMissense
2813 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:35726384:T:C | F106L | 0.877 |
| 22:35726386:T:A | F106L | 0.877 |
| 22:35726386:T:G | F106L | 0.877 |
| 22:35726831:T:C | F255L | 0.869 |
| 22:35726833:C:A | F255L | 0.869 |
| 22:35726833:C:G | F255L | 0.869 |
| 22:35726564:A:C | S166R | 0.846 |
| 22:35726566:T:A | S166R | 0.846 |
| 22:35726566:T:G | S166R | 0.846 |
| 22:35726372:T:C | F102L | 0.824 |
| 22:35726374:T:A | F102L | 0.824 |
| 22:35726374:T:G | F102L | 0.824 |
| 22:35726906:T:C | F280L | 0.815 |
| 22:35726908:T:A | F280L | 0.815 |
| 22:35726908:T:G | F280L | 0.815 |
| 22:35726876:T:C | F270L | 0.802 |
| 22:35726878:C:A | F270L | 0.802 |
| 22:35726878:C:G | F270L | 0.802 |
| 22:35726852:T:C | F262L | 0.796 |
| 22:35726854:T:A | F262L | 0.796 |
| 22:35726854:T:G | F262L | 0.796 |
| 22:35726427:T:C | L120P | 0.777 |
| 22:35726438:G:C | A124P | 0.769 |
| 22:35726538:C:A | A157D | 0.759 |
| 22:35726508:T:A | V147D | 0.750 |
| 22:35726606:G:C | A180P | 0.748 |
| 22:35726469:T:C | L134P | 0.736 |
| 22:35727058:A:C | R330S | 0.733 |
| 22:35727058:A:T | R330S | 0.733 |
| 22:35726399:T:C | F111L | 0.730 |
dbSNP variants (sampled 300 via entrez): RS1000023230 (22:35727774 A>G), RS1000085795 (22:35721453 G>C), RS1000138979 (22:35707758 A>G), RS1000235641 (22:35712065 G>T), RS1000301863 (22:35716966 A>G), RS1000319154 (22:35722957 T>C), RS1000387332 (22:35715593 G>A), RS1000435312 (22:35722670 G>C), RS1000459653 (22:35727352 G>C), RS1000652555 (22:35716733 A>C,T), RS1000731148 (22:35706620 C>T), RS1000790405 (22:35712300 C>T), RS1001016959 (22:35706761 G>A), RS1001260856 (22:35711169 C>T), RS1001281295 (22:35727393 A>C)
Disease associations
OMIM: gene MIM:607255 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002301_5 | Body mass index | 3.000000e-06 |
| GCST005958_13 | Waist-to-hip ratio adjusted for BMI (age >50) | 1.000000e-06 |
| GCST005962_33 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 6.000000e-06 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Rotenone | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.